1 / 9

Vaccines Market to grow at 9% CAGR from 2017 to 2024

Get more details @ http://bit.ly/2zKasVN <br>Some of the major players in vaccines market are AstraZeneca, Abbott, Bristol-Myers Squibb, Merck & Co., Johnson & Johnson, Sanofi Pasteur, Pfizer, GlaxoSmithKline, Emergent BioSolutions, Novartis, Astellas Pharma, CSL and Novavax.

jueekate
Download Presentation

Vaccines Market to grow at 9% CAGR from 2017 to 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Vaccines Market to hit $65 Bn by 2024: Global Market Insights Inc.

  2. Key Insights from VaccinesMarket: • The global vaccines market has recently witnessed one of its key participants, Novartis NVS announcing its decision to acquire the France based radiopharmaceutical company, Advanced Accelerator Applications (AAAP). • Global Market Insights, Inc. says, in 2016, vaccines market size stood at a revenue of USD 32 billion. • This purchase apparently, is expected to strengthen Novartis’ product portfolio in the cancer vertical, by adding AAAP’s RadioLigand Therapy. • Currently, it has been observed most of the pharmaceutical giants have been striving to come up with innovative vaccination products for influenza, which seems to be raging across the globe in seasonal intervals. • The company also plans to recruit more workforce to increase the production rate, so that the vaccines can be shipped in readiness in case of a pandemic. • Seqirus’s investment is likely to encourage regional vaccines industry players to follow suit, which would subsequently help stimulate UK vaccines market trends over the coming years.

  3. Continued... • Regulatory organizations have been making continuous efforts to generate awareness among the global populace regarding the advantages of vaccination. • For instance, the U.S. Centers for Disease Control and Prevention (CDC) has inked guidelines to encourage people to take seasonal influenza vaccines for controlling and preventing the virus from spreading, especially in young children, the elderly, and pregnant women. • As per estimates, U.S. covered a major share of the regional vaccines market revenue in 2016, pertaining to the numerous efforts undertaken by regulatory bodies. • Considering the myriad advantages that vaccines provide to improve an individual’s immunity system, researchers have been striving to conduct eminent study programs involving the methodology of combining vaccines with other cancer treatment methods such as radiations, chemotherapy, and Herceptin to enhance patient survival rate. • Notable behemoths across the vaccines market, namely, Merck & Co., AstraZeneca, Pfizer, Novartis, Bristol-Myers Squibb, CSL, Johnson & Johnson, Abbott, GlaxoSmithKline, Astellas Pharma, Sanofi Pasteur, Novavax, and Emergent BioSolutions

  4. U.S. Vaccines Market, By Age Group, 2013 - 2024 (USD Billion)

  5. Table of Content: • Chapter 1. Methodology • 1.1. Methodology • 1.1.1. Initial data exploration • 1.1.2. Statistical modeling and forecast • 1.1.3. Industry insights and validation • 1.1.4. Market definition and forecast assumptions • 1.2. Data sources • 1.2.1. Primary • 1.2.2. Secondary • Chapter 2. Executive Summary • 2.1. Global Vaccines industry 3600 synopsis, 2013 - 2024 • 2.1.1. Business trends • 2.1.2. Age group trends • 2.1.3. Disease trends • 2.1.4. Technology trends • 2.1.5. Regional trends

  6. Table of Content: • Chapter 3. Vaccines Industry Insights • 3.1. Industry segmentation • 3.2. Industry landscape, 2013 – 2024 • 3.3. Industry impact forces • 3.3.1. Growth drivers • 3.3.1.1.Increasing government funding for vaccine development • 3.3.1.2. Increasing vaccines R&D in developed nations • 3.3.1.3. Increasing disease prevalence in underdeveloped countries • 3.3.1.4. Growing incidences of cancer & HIV in Asia Pacific • 3.3.2. Industry pitfalls & challenges • 3.3.2.1. High cost of vaccine storage and transportation • 3.3.2.2. Stringent regulations for the approval of vaccines in developed nations • 3.4. Growth potential analysis • 3.4.1. By age group • 3.4.2. By technology • 3.4.3. By disease

  7. Table of Content: • 3.5. Regulatory landscape • 3.5.1. U.S • 3.5.2. Europe • 3.5.3. Asia Pacific • 3.6. Reimbursement scenario • 3.6.1. U.S • 3.6.2. Europe • 3.7. Technology landscape • 3.8. Pricing analysis • 3.9. Pipeline product analysis • 3.9.1. Malaria • 3.9.2. HIV • 3.9.3. Zika • 3.9.4. Ebola • 3.10. Porter’s analysis • 3.11. Company market share analysis, 2016 • 3.11.1. Strategy dashboard • 3.12. PESTEL analysis

  8. Browse Full Market Research Report On Vaccines Market @ http://bit.ly/2A49oxa Request for a Sample of this Research Report @ https://www.gminsights.com/request-sample/detail/2186https://www.gminsights.com/request-sample/detail/49

  9. Stay In Touch Website: www.gminsights.com Social Media:

More Related